Levetiracetam Tablet, Extended Release
Product Images NDC 13668-300

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 13668-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ectdmodule1usa1

Chemical structure of levetiracetam, the active ingredient in the drug LEVETIRACETAM. The structure depicts a pyrrolidone ring linked to an ethyl group and an amide functional group.*

FDA Label Image

Ectdmodule1usa2

A bar chart comparing the percentage of patients across three groups: placebo, immediate-release levetiracetam 1000 mg/day, and immediate-release levetiracetam 3000 mg/day. The chart shows patient percentages on the y-axis and treatment groups on the x-axis, with higher percentages for the levetiracetam groups compared to placebo.*

FDA Label Image

Ectdmodule1usa3

A bar graph displaying percentages of patients across three groups: Placebo (6.3%), Immediate-release Levetiracetam 1000 mg/day (20.8%), and Immediate-release Levetiracetam 2000 mg/day (35.2%). The x-axis shows treatment groups with sample sizes, and the y-axis represents percentage of patients from 0% to 45%.*

FDA Label Image

Ectdmodule1usa4

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Immediate-release Levetiracetam 3000 mg/day (N=180) with 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Ectdmodule1usa5

A bar graph comparing the percentage of patients between two groups: Placebo (N=97) and Immediate-release Levetiracetam (N=101). The graph shows approximately 19.6% for the placebo group and 44.6% for the immediate-release levetiracetam group along the y-axis labeled '% of Patients.'*

FDA Label Image

Ectdmodule1usa6

FDA Label Image

Ectdmodule1usa7

FDA Label Image

Levetirac Exte 500 500t

Label of Levetiracetam Extended-Release Tablets, USP 500 mg showing 500 tablets in the package. The label includes storage instructions, manufacturer Torrent Pharmaceuticals Limited, and distributor Torrent Pharma Inc. It specifies once daily dosing, child-resistant packaging, and is marked Rx only. The NDC number 13668-272-05 is also visible.*

FDA Label Image

Levetirac Exte 750 500t

Label for Levetiracetam Extended-Release Tablets USP 750 mg by Torrent Pharmaceuticals Limited. The label states 500 tablets per container, intended for oral use, with NDC 13668-300-05. It includes storage instructions, manufacturing details, and dosing guidance noting once daily dosing and Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.